Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery
Status:
Completed
Trial end date:
2018-09-04
Target enrollment:
Participant gender:
Summary
This phase I trial studies the side effects and best dose of photodynamic therapy during
surgery in treating patients with non-small cell lung cancer that can be removed by surgery.
Photodynamic therapy uses a drug, such as temoporfin, that becomes active when it is exposed
to a certain kind of light. When the drug is active, cancer cells are killed. This may be a
better way to treat patients with non-small cell lung cancer.